CNS Announces the FDA has Granted Orphan Drug Designation for Brain Cancer Drug Berubicin Jun 11, 2020 8:00am EDT
CNS Pharmaceuticals Announces Sponsored Research Agreement with MD Anderson for Potential Cancer Treatment Technologies May 28, 2020 8:00am EDT